Home > Journals > Esperienze Dermatologiche > Past Issues > Esperienze Dermatologiche 2013 December;15(4) > Esperienze Dermatologiche 2013 December;15(4):143-51



To subscribe
Submit an article
Recommend to your librarian





Esperienze Dermatologiche 2013 December;15(4):143-51


language: Italian

Adherence in topical treatments for psoriasis. Consensus paper

Sedona P. 1, De Pità O. 2, Ricciuti F. 3, Cusano F. 4, Bellosta M. 4, Battarra V. C. 5, Simonetti S. 6, Bettoli V. 7, Nobile C. 8, Pellicano R. 9, Zichichi L. 10, Cristaudo A. 11, Mazzatenta C. 12

1 Unità Operativa di Dermatologia, Ospedale SS. Giovanni e Paolo, Azienda Ulss 12 Veneziana, Venezia, Italia; 2 Laboratorio Immunologia e Allergologia IDI-IRCCS, Roma, Italia; 3 Vice-Presidente ADOI, Sorrento, Napoli, Italia; 4 Unità Operativa Complessa di Dermatologia, Azienda Ospedaliera “Gaetano Rummo”, Benevento, Italia; 5 Unità Operativa Semplice Dipartimentale di Dermatologia Oncologica e Chirurgia delle Neoformazioni Cutanee, Azienda Ospedaliera “Sant’Anna e San Sebastiano”, Caserta, Italia; 6 Clinica Dermatologica, Azienda Ospedaliera di Perugia, Perugia, Italia; 7 Dipartimento di Medicina Clinica e Specialistica - Sezione di Dermatologia, Azienda Ospedaliero-Universitaria di Ferrara, Ferrara, Italia; 8 Reparto Dermatologia, Azienda Sanitaria dell’Alto Adige, Comprensorio Sanitario di Brunico, Bolzano, Italia; 9 Unità Operativa Complessa di Dermatologia, Ospedale “Casa Sollievo della Sofferenza”, San Giovanni Rotondo, Foggia, Italia; 10 Unità Operativa Complessa di Dermatologia, Ospedale S. Antonio Abate, Azienda Sanitaria Provinciale di Trapani, Erice Casa Santa, Trapani, Italia; 11 Unità Operativa Complessa di Dermatologia Infettiva e Allergologica, IFO - Istituto San Gallicano – IRCCS, Roma, Italia; 12 Unità Operativa di Dermatologia ASL 2, Lucca, Italia


The effectiveness of drug treatment is influenced by the level of patient adherence to therapy. Psoriasis is a chronic and very visible illness, whose treatment, especially if based on topical therapies, can have consequences on the lifestyle of the patient to an extent that will adversely affect adherence. With a view to improving adherence, this paper identifies two possible areas of action: handling communication with the patient and choosing a treatment that adapts to the patient’s needs. On the basis of studies on the adherence of psoriasis patients to topical therapies, it is evident that patients prefer treatments with good cosmetic characteristics, rapid efficacy and single daily application. A good response to the needs of patients is the association between calcipotriol and betamethasone dipropionate, combined with innovative vehicles such as a non-alcoholic gel. Physicians may also encourage high adherence, and thus increase the effectiveness of topical therapies, by establishing a collaborative relationship with their patients, in which the patient is involved in treatment decisions, educated on how to perform the treatment and on the importance of adherence, with regular follow-up visits.

top of page